Perrigo to Sell Dermacosmetics Business

Perrigo Co., which manufactures generic medications and consumer self-care brands such as Dermalex, Coldrex and NiQuitin, is looking to offload its dermacosmetics business, which includes the brands ACO, Biodermal, Emolium and Iwostin.

Perrigo’s dermacosmetics business generated approximately $146 million in net sales in calendar year 2024, accounting for approximately 5% of Perrigo’s 2024 adjusted operating income.

The transaction is expected to close in the first quarter of 2026.